By all accounts, biopharmaceuticals are the supernovae in the pharma firmament. In an article in Pharmaceutical Technology’s August 2010 Outsourcing Resources supplement, for example, Datamonitor’s Bornadata Bain and John Shortmoor suggested that by 2014, sales of small molecules would shrink by $17 billion, while sales of monoclonal antibodies alone would increase by $23 billion. Given that, the editors of Pharmaceutical Technology want to hear from all those in the development and manufacture of biopharmaceuticals about what you produce and how you produce them. Click here to fill out the survey. Responses will be kept confidential, and the results will be published in Pharmaceutical Technology’s May 2011 supplement on Sterile Manufacturing and Bioprocessing. Those of you who complete the survey will have a chance to win a $100 gift certificate.